Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities
29 juil. 2024 07h00 HE
|
Tilray Brands, Inc.
NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in medical cannabis research, cultivation, production, and...
Tilray Provides International Cannabis Update on Milestone German Cannabis Legalization
28 févr. 2024 07h00 HE
|
Tilray Brands, Inc.
Tilray is bullish on the positive paradigm shift that the new German drug policy creates for the future of cannabis in Europe.